Kim Fuller is currently the Associate Vice President of Global Medical and Safety Sciences Strategy at Eli Lilly & Company, a position held since 2025. Previously, Kim has held various roles in drug safety and pharmacovigilance, including Associate Director of Clinical Safety Operations at Cascadian Therapeutics, Director of Case Management Operations at Bristol Myers Squibb, and Senior Director of Drug Safety at POINT Biopharma. Kim's experience spans several companies, including Acucela Inc. and Poniard Pharmaceuticals, where they specialized in safety report processing and compliance with regulatory standards. Kim holds a Bachelor of Science in Nursing and a Master's in Business Administration with a focus on Leadership Studies from Madonna University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices